Response to venetoclax‐containing regimens in patients with relapsed/refractory (R/R) T‐cell acute lymphoblastic leukaemia (T‐ALL) and lymphoblastic lymphoma (T‐LBL)
Miles Thomas, Apoorva Ravichandran, Emily Dworkin, Caner Saygin, Adam DuVall, Wendy Stock et al. Response to venetoclax‐containing regimens in patients with relapsed/refractory (R/R) T‐cell acute lymphoblastic leukaemia (T‐ALL) and lymphoblastic lymphoma (T‐LBL). // British Journal of Haematology. – 2026. – DOI: 10.1111/bjh.70960. – URL: https://onlinelibrary.wiley.com/doi/10.1111/bjh.70960?af=R
Miles Thomas, Apoorva Ravichandran, Emily Dworkin, Caner Saygin, Adam DuVall, Wendy Stock, & Anand A. Patel (2026). Response to venetoclax‐containing regimens in patients with relapsed/refractory (R/R) T‐cell acute lymphoblastic leukaemia (T‐ALL) and lymphoblastic lymphoma (T‐LBL). British Journal of Haematology. https://doi.org/10.1111/bjh.70960
Miles Thomas, et al. “Response to venetoclax‐containing regimens in patients with relapsed/refractory (R/R) T‐cell acute lymphoblastic leukaemia (T‐ALL) and lymphoblastic lymphoma (T‐LBL).” British Journal of Haematology, 2026. doi:10.1111/bjh.70960.
@article{Thomas2026,
title = {Response to venetoclax‐containing regimens in patients with relapsed/refractory (R/R) T‐cell acute lymphoblastic leukaemia (T‐ALL) and lymphoblastic lymphoma (T‐LBL)},
author = {Thomas, Miles and Ravichandran, Apoorva and Dworkin, Emily and Saygin, Caner and DuVall, Adam and Stock, Wendy and Patel, Anand A.},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70960},
url = {https://onlinelibrary.wiley.com/doi/10.1111/bjh.70960?af=R}
}